Ajanta Pharma Q2 FY27 earnings call on 30 October 2026

Board & Shareholder Meetings View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹3359.80

prior close

₹3372.50

announcement price

After-mkt

timing

Nifty Midcap 150market-0.1%-1.1% vs market

Pharmaceuticals peers, median of 173sector+0.1%-1.3% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Midcap 150 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-0.7

15m

-0.8

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2-0.1-1.1+0.1-1.3

Next day

-1.9-1.2-0.7-1.2-0.7

-3.0-2.6-0.4-2.8-0.1

-2.6-3.3+0.8-3.9+1.3

-2.2-5.3+3.1-5.1+2.9

+1.5-4.3+5.8-3.9+5.4

+3.1pendingpending-0.9+4.1

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajanta Pharma will release its Q2 FY2027 unaudited financial results on 30 October 2026, following a Board meeting. The company will host an earnings conference call at 16:00 hrs IST for investors and analysts, where the leadership team will discuss financial performance and take questions. Dial-in details for India, USA, UK, Hong Kong, and Singapore are provided. A call transcript and playback will be available on the company website.

Likely market impact

Earnings results and management commentary may move the stock; investors should watch for Q2 performance details on call day.